Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript [15]

Leukemia

Volumn 20, Issue 1, 2006, Pages 167-168

  Tchirkov, Andrei ^a,b   Couderc, J L ^c   Perissel B ^b   Goumy, C ^b   Regnier, A ^d   Uhrhammer, N ^a   Verrelle, P ^a   Berger, M ^e  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c INSERM   (France)

^d Service de Medecine Interne   (France)

^e ONERA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HEMOGLOBIN; IMATINIB; MESSENGER RNA;

ADULT; BASOPHIL; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DISEASE COURSE; EOSINOPHIL; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; INTRON; LETTER; LEUKEMIA REMISSION; LEUKOCYTE COUNT; LYMPHOCYTE; MALE; METAPHASE; MOLECULAR GENETICS; MONOCYTE; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROMYELOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOP CODON; THROMBOCYTE COUNT;

EID: 33644968842     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404012     Document Type: Letter

References (5)

1. Demehri S, Paschka P, Schultheis B, Lange T, Koizumi T, Sugimoto T et al. e8a2 BCR-ABL: More frequent than other atypical BCR-ABL variants? Leukemia 2005; 19: 681-684.
2. Martiat P, Mecucci C, Nizet Y, Stul M, Philippe M, Cassiman JJ et al. P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma. Leukemia 1990; 4: 751-754.
3. Cashman JD, Eaves CJ, Sarris AH, Eaves AC. MCP-1, not MIP-lalpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures. Blood 1998; 92: 2338-2344.
4. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003; 17: 2318-2357.
5. Cortes J, Talpaz M, O'Brien S, Jones D, Luthra R, Shan J et al. Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate. Clin Cancer Res 2005; 11: 3425-3432.